Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Incyte Corp (NASDAQ:INCY)

Tuesday’s trading has closed, but INCY is being traded in the after-hours session. After-Hours quote »
109.74
Delayed Data
As of 3:59pm ET
 +5.76 / +5.54%
Today’s Change
43.86
Today|||52-Week Range
121.70
+50.10%
Year-to-Date
No recent news for Incyte Corp.

Today’s Trading

Previous close103.98
Today’s open109.23
Day’s range105.23 - 111.42
Volume1,798,036
Average volume (3 months)946,316
Market cap$18.7B
Dividend yield--
Data as of 3:59pm ET, 08/04/2015

Growth & Valuation

Earnings growth (last year)+48.21%
Earnings growth (this year)+7.87%
Earnings growth (next 5 years)+219.00%
Revenue growth (last year)+44.10%
P/E ratioNM
Price/Sales24.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ENDPEndo International P...-1.88-2.16%
HSPHospira Inc+0.07+0.08%
MNKMallinckrodt Plc-17.48-14.07%
BMRNBiomarin Pharmaceuti...-3.39-2.30%
Data as of 4:14pm ET, 08/04/2015

Financials

Last reporting dateAugust 4, 2015
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$511.5M
Annual profit (last year)-$48.5M
Net profit margin-9.48%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts